Clinical outcomes and overview of dedicated venous stents for management of chronic iliocaval and femoral deep venous disease.


Journal

Vascular
ISSN: 1708-539X
Titre abrégé: Vascular
Pays: England
ID NLM: 101196722

Informations de publication

Date de publication:
Apr 2022
Historique:
pubmed: 6 4 2021
medline: 7 4 2022
entrez: 5 4 2021
Statut: ppublish

Résumé

Venous stenting of the lower extremities has grown in popularity and is now considered a key component of the primary treatment strategy for the management of pathologically obstructive or stenotic lesions of the deep venous system. This review aims to provide an overview of the role of venous stenting in the management of chronic conditions affecting the deep venous system of the lower limbs. An overview of venous stents design and current role of stenting procedure in individuals presenting with Chronic Venous Insufficiency (CVI) and presenting the current trials of dedicated venous stenting in management of chronic deep venous lesions. This review provides a focused insight on venous stent design, physical properties and the available dedicated venous stents selected studies with their related patency outcome based on selective literature search of the PubMed database and Cochrane library. Dedicated venous stent technology is advancing at a rapid pace alongside the increased undertaking of endovascular deep venous stent reconstruction in the management of iliocaval vein pathologies. The ideal design(s) for venous stents remain unknown, although it is hoped that the presence of new dedicated venous stents in clinical practice will allow the generation of experience and data to advance our understanding in this area.

Identifiants

pubmed: 33813974
doi: 10.1177/1708538121989860
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

320-330

Auteurs

Mohamed Ah Taha (MA)

Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London, UK.
Department of Vascular and Endovascular Surgery, Faculty of Medicine, Assiut University Hospitals, Assiut University, Egypt.

Andrew Busuttil (A)

Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London, UK.

Roshan Bootun (R)

Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London, UK.

Bahgat Ah Thabet (BA)

Department of Vascular and Endovascular Surgery, Faculty of Medicine, Assiut University Hospitals, Assiut University, Egypt.

Ayman Eh Badawy (AE)

Department of Vascular and Endovascular Surgery, Faculty of Medicine, Assiut University Hospitals, Assiut University, Egypt.

Haitham A Hassan (HA)

Department of Vascular and Endovascular Surgery, Faculty of Medicine, Assiut University Hospitals, Assiut University, Egypt.

Joseph Shalhoub (J)

Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London, UK.
Imperial Vascular Unit, Imperial College Healthcare NHS Trust, London, UK.

Alun H Davies (AH)

Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London, UK.
Imperial Vascular Unit, Imperial College Healthcare NHS Trust, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH